A detailed history of Vanguard Group Inc transactions in Semler Scientific, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 311,624 shares of SMLR stock, worth $23.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
311,624
Previous 313,517 0.6%
Holding current value
$23.3 Million
Previous $10.8 Million 31.95%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$22.3 - $36.21 $42,213 - $68,545
-1,893 Reduced 0.6%
311,624 $7.34 Million
Q2 2024

Aug 13, 2024

SELL
$21.03 - $40.57 $124,013 - $239,241
-5,897 Reduced 1.85%
313,517 $10.8 Million
Q1 2024

May 10, 2024

SELL
$28.42 - $51.54 $357,040 - $647,497
-12,563 Reduced 3.78%
319,414 $9.33 Million
Q4 2023

Feb 14, 2024

BUY
$25.66 - $46.29 $106,155 - $191,501
4,137 Added 1.26%
331,977 $14.7 Million
Q3 2023

Nov 14, 2023

BUY
$23.15 - $28.54 $303,195 - $373,788
13,097 Added 4.16%
327,840 $8.32 Million
Q2 2023

Aug 14, 2023

BUY
$22.5 - $30.58 $696,060 - $946,022
30,936 Added 10.9%
314,743 $8.26 Million
Q1 2023

May 15, 2023

BUY
$19.28 - $41.74 $924,668 - $2 Million
47,960 Added 20.34%
283,807 $7.61 Million
Q4 2022

Feb 10, 2023

BUY
$28.01 - $43.49 $289,427 - $449,382
10,333 Added 4.58%
235,847 $7.78 Million
Q3 2022

Nov 14, 2022

BUY
$27.75 - $45.8 $66,600 - $109,920
2,400 Added 1.08%
225,514 $8.47 Million
Q2 2022

Aug 12, 2022

BUY
$27.86 - $50.32 $693,714 - $1.25 Million
24,900 Added 12.56%
223,114 $6.29 Million
Q1 2022

May 13, 2022

BUY
$42.24 - $93.25 $11,320 - $24,991
268 Added 0.14%
198,214 $9.82 Million
Q4 2021

Feb 14, 2022

BUY
$89.61 - $149.99 $17.7 Million - $29.7 Million
197,946 New
197,946 $18.1 Million

Others Institutions Holding SMLR

About Semler Scientific, Inc.


  • Ticker SMLR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 6,800,580
  • Market Cap $508M
  • Description
  • Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's va...
More about SMLR
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.